Capital Rx vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Capital Rx is a New York-based health technology company offering a transparent pharmacy benefits management (PBM) platform and enterprise health ecosystem (JUDI) for self-insured employers and health plans; raised $109M Series C in 2022;
About
Capital Rx is a New York-based health technology company founded in 2017 by AJ Loiacono and Justin Vattimo. It operates as a transparent pharmacy benefits manager (PBM) and health platform for self-insured employers and health plans, positioned as an alternative to the three dominant incumbent PBMs — CVS Caremark, Express Scripts, and OptumRx — whose bundled pricing models have faced sustained criticism for opacity and misaligned rebate incentives. Capital Rx's core differentiator is its CPEC (Clearinghouse PBM Employer Coalition) pricing model, which passes drug rebates and discounts directly to plan sponsors rather than retaining them as revenue — a structurally transparent approach that the company claims delivers demonstrable cost savings over traditional PBM arrangements.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.